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Abstract— There are multiple concerns surrounding the 
development and rollout of self-driving cars. One issue has 
largely gone unnoticed - the adverse effects of motion sickness 
as induced by self-driving cars. The literature suggests 
conditionally, highly and fully autonomous vehicles will increase 
the onset likelihood and severity of motion sickness. Previous 
research has shown motion sickness can have a significant 
negative impact on human performance. This paper uses a 
simulator study design with 51 participants to assess if the scale 
of motion sickness is a predictor of human performance 
degradation. This paper finds little proof that subjective motion 
sickness severity is an effective indicator of the scale of human 
performance degradation. The performance change of 
participants with lower subjective motion sickness is mostly 
statistically indistinguishable from those with higher subjective 
sickness. Conclusively, those with even acute motion sickness 
may be just as affected as those with higher sickness, considering 
human performance. Building on these results, it could indicate 
motion sickness should be a consideration for understanding 
user ability to regain control of a self-driving vehicle, even if not 
feeling subjectively unwell. Effectiveness of subjective scoring is 
discussed and future research is proposed to help ensure the 
successful rollout of self-driving vehicles. 
I. INTRODUCTION  
The independent consultancy – KPMG estimate that “all 
vehicles produced in the UK by 2027 will have at least L3 
technologies” [1], where L3 refers to Level 3 conditional 
automation [2]. Automakers have made significant steps 
towards such goals in recent years, but there are still many 
factors as yet unknown and in need of further development if 
the rollout of such technology can be realised. Further to the 
amass of technical and legislative barriers for self-driving and 
autonomy, there are still a multitude of human factors 
concerns in relation to the use of self-driving vehicles, from 
mode confusion at points of hand over to user interface design. 
This paper however looks at another important issue - that of 
motion sickness (MS) as a result of ‘users’ travelling in a self-
driving car.  
MS is commonly understood to be a comfort issue for self-
driving vehicles, and rightly so. However, this paper will 
explore an as-yet unconsidered area of human performance. 
Levels 3 and 4 autonomy (in accordance to SAE guidelines 
[2]) dictate the need for a substantial human consideration. 
Where in level 3, or ‘conditional driving automation’, the 
driver may be expected to take back control of the vehicle at 
any time and level 4, ‘high driving automation’, will also 
allow the driver to take control of the vehicle (although it is 
not a requirement). Considering autonomy states such as 
conditional and high automation there is an even greater need 
for resolving human factors issues prior to a successful roll out 
of self-driving vehicles. One such area of concern is the 
vehicle handover point (i.e., where the user is expected to 
relinquish control of the vehicle to the self-driving system, or 
regain control after a period of automated driving, aka 
takeover). Much research has been conducted assessing 
various issues concerned with vehicle handover, with 
particular focus on areas such as “the situational awareness 
level of the driver and the vehicle, the knowledge the vehicle 
must have of the driver's driving skills as well as the in-vehicle 
context” [3]. One considerable issue, however, has gone 
largely unnoticed – the physical, cognitive and visual capacity 
of a driver if a self-driving car does indeed induce motion 
sickness. 
Considering MS, it is understood that “around 60% of the 
population has experienced some nausea from car travel, 
whereas about a third has vomited in cars before the age of 
12” [4]. Aside from vomiting, MS “is typically preceded by 
signs and symptoms such as nausea, headache, fatigue, and 
drowsiness which may linger on for hours” [4]. Other than the 
obvious concern for passenger comfort, MS has been a fairly 
insignificant factor in the development of traditional vehicles 
mainly because of the low likelihood of drivers becoming 
motion sick. However, when considering self-driving vehicles 
(particularly levels 3 and 4 and 5 automated vehicles) the 
consideration of MS is of much greater importance. It is 
expected that self-driving vehicles are likely to significantly 
increase MS onset frequency and severity as drivers become 
‘passengers’ and as people engage in other non-driving related 
activities such as reading or working [5]. Outside of the 
automotive domain, research has touched on the relationship 
between MS and task completion ability in users, although 
most studies have been industry specific and use non-
transferable measurements (of both human performance and 
MS). Previous work conducted by the authors [6] has shown 
how MS does indeed negatively affect cognitive, physical, 
physical-visual and physical-cognitive performance, although 
the scale of this impact is unknown. It is speculated that the 
impact of such MS on human performance could affect the 
ability of users to regain control of a vehicle or make 
appropriate context based decisions - as is required in 
conditional driving automation (level 3), and as is possible in 
high driving automation (level 4). Ensuring the human is in a 
fit state to drive must be a key element of the human-machine 
interaction involved in the development of self-driving 
vehicles. This paper therefore aims to address the current state 
of research in this subject area and with independently 
Lead author sponsored by Jaguar Land Rover, UK. 
collected data, it will look to understand the scale of the extent 
to which MS can affect human performance. 
II. MOTION SICKNESS – WHAT IS IT 
Motion sickness (MS) is an umbrella term for a variety of 
motion (or perceived motion) induced ‘sickness’ which covers 
things such as seasickness, carsickness, visually induced MS 
(VIMS), simulation sickness etc.  It is important to note that 
when a person is reported to be experiencing ‘motion sick’, at 
the low end of the scale they may not even be feeling ‘sick’ at 
all. For example, reports of increased salivation and fatigue 
may indicate a MS score, although few people would actually 
consider themselves ‘sick’, or even uncomfortable. However, 
in the more advanced stages of MS the symptoms can be very 
uncomfortable and indeed result in being physically sick. The 
most accepted theory to explain the cause of MS is the 
Sensory Conflict Theory. The theory explains that 
“mismatches between (or within) the visual, vestibular, and 
somatosensory inputs” cause MS [7].  This essentially means 
that if movement is sensed for example, within the inner ear, 
which does not correlate to the motion that is seen by the eye, 
then there is a conflict of senses and MS prevails. This conflict 
can arise if the human eye sees movement around it, but the 
inner ear senses no motion, or vice-versa. MS through sensory 
conflict can also arise through more acute mismatches, such 
as if the eye sees lots of movement, but the vestibular system 
senses only slight. 
The theory of Postural Instability is also considered to be 
related to motion sickness. The central hypothesis of postural 
instability theory is that MS is caused by loss of postural 
control [8]. More recent studies have shown postural 
instability may not necessarily cause MS, but does precede 
subjective MS symptoms [9]. 
III. MOTION SICKNESS IN SELF-DRIVING VEHICLES 
With the knowledge of these two theories of MS it is possible 
to see why self-driving vehicles may pose more of a problem 
for MS onset likelihood and severity than conventional 
vehicles. One very useful paper in this field, lists three areas 
that contribute to self-driving vehicle MS: “Changing roles: 
From driver to passenger, Engagement in non-driving 
activities and flexible seating arrangements” [5]. As such, 
when people switch between being an active driver to a 
passive occupant (or passenger) many things change, 
including the freedom to engage in other activities. Firstly, 
where a driver is traditionally looking at the road and inputting 
movement controls through the steering wheel and pedals, 
they are fully aware of the movement they are immediately 
subjected to and any future movement too. In line with the 
postural instability theory, a traditional driver can predict 
upcoming motion and scan the road ahead. However, when 
the person becomes a ‘passenger’ they are unaware of the 
future motions as they are not inputting motion controls. 
Therefore, it is harder to predict future motion and cognate 
current accelerations – here MS may prevail.  
Considering sensory conflict theory, a traditional driver 
will sense movement within their inner ear which will 
correlate to the movement observed through their eyes as they 
see the road, so there is no sensory conflict when driving. 
However, if reading a book, or engaging in other non-driving 
related activities as levels 3, 4 and 5 automated vehicles may 
allow, the majority of the field of vision is static although 
movement is still detected by the inner ear. In this second 
instance, it is possible that sensory conflict and MS will 
prevail. 
 Considering self-driving cars, it has been theorised that 
“all envisaged use cases can be predicted to increase the risk 
of motion sickness” [10]. One paper looking at MS likelihood 
of adults riding as passengers in self-driving cars found that, 
37% of Americans, 40% of Chinese, 53% of Indian people 
would “experience an increase in the frequency and severity 
of motion sickness” [11]. However, they also added that the 
“actual frequency and severity of motion sickness in self-
driving vehicles might be greater than calculated” mainly due 
to the variation in activities passengers could engage in, and 
potential design changes in such vehicles (which include 
variability in ride dynamics which affect low frequency 
vibration – another effector of MS). Things are worsened 
further when flexible seating is considered – where “numerous 
concepts for autonomous vehicles suggest flexible interior 
layouts which frequently involve swivelling chairs allowing 
the driver and front passenger to turn to the rear passengers” 
[5]. 
A survey conducted by StateFarm in 2016 [12] looked to 
understand what people want to do within a self-driving car, 
given the premise that self-driving technology would free up 
their time to engage in other activities. They reported 45% of 
people would be more willing to read texts, 36% would be 
more willing to access the internet, 21% would be more 
willing to watch movies and 19% would be more willing to 
read a book – all tasks expected to increase MS onset/severity. 
Further, Morgan Stanley go on to estimate ‘productivity gains 
would come to $507 billion annually in the US’ [13] through 
the introduction of self-driving cars. Pointing to the 
expectation that users will want, or perhaps even be expected 
to, engage in work-related tasks which are known to increase 
MS. Considering also saleability of these vehicles, the 
literature has shown MS susceptibility can vary between age 
groups, genders and ethnicities (amongst other factors) [14] 
[15]. Modern automakers have a diverse customer base with 
different cars targeted at different demographics. There is 
therefore, a high chance some customers will be much more 
susceptible than others, making it critical that MS is accounted 
for across the entire demographic so that groups are not 
excluded or inadvertently ‘designed out’ of ownership. This 
concern falls within the inclusive design requirements that 
automakers are expected to follow. Conclusively, considering 
only activities occupants can engage in, a conservative 12% 
of American adults, 13% of Chinese adults and 17% of Indian 
adults would experience moderate or severe MS [11] and as 
such, there is a pressing need for further research to 
understand the impact. 
IV. MOTION SICKNESS AND HUMAN PERFORMANCE 
Considering cognitive task performance, one study found 
5% of their users did not complete a task when not feeling 
‘sick at all’, however “this increased to about 60%” when 
seasick [16] where the task was a job-related assessment. 
Researchers also found “a highly significant effect of 
seasickness on acuities” [17] where visual acuity is the ability 
to visually perceive detail. Colwell et al. [18] showed how 
cognitive task performance decreased with increased MS. A 
2005 NASA sponsored project found that it is possible to 
increase task completion ability significantly by reducing MS 
[19] - although the exact effect was not quantified. A US 
military project advised that if a person reports MS whilst 
using their tank simulator they “should not be required to 
drive any (real-world) vehicle” [20] on account of their 
expected decreased task performance ability. Research 
projects using driving/flying simulators often recommend 
people should not be expected to drive a real world vehicle 
immediately after the study because it is believed MS “can 
affect performance after the simulator experience” [21]. This 
is based on the findings that use of virtual environments 
“could directly affect visuo-motor coordination” [22].  
Despite these findings, the effect of MS on automotive-
based task completion is a relatively under-researched area 
where the papers previously discussed are not directly 
transferable few reasons. Most importantly, none of the task 
completion tests sufficiently covers the breadth of task 
completion requirements a driver is expected to perform, 
where all of the ‘performance’ scoring had been in relation to 
job/task specific assessments. Secondly, the scale of the 
impact is rarely considered where the severity of motion 
sickness has not been correlated to the scale of human 
performance impact.  Task requirements for driving a car 
include cognitive, visual and physical abilities. Where 
cognitive function is required for mental abilities in 
processing demands, route planning, appraising danger etc. 
Visual ability is required to identify targets, scan the road, 
read signs/directions and identify dangers etc. And physical 
tasks are related to the ability to manually control a vehicle/ 
system interface through dexterous interaction, motor 
coordination, interaction with controls etc. A breakdown of 
task completion abilities drivers need is presented below in 
Fig. 1 where the intersections between tasks are also of 
importance. Auditory ability has been omitted as the ability 
to hear is not required for driving. 
 
 
 
 
 
 
 
Fig. 1. Human performance areas for driving 
Using this breakdown of human performance, previous 
research by the authors showed that motion sickness (as 
induced by a simulator) significantly negativly affects 
cognitive, physical, physical-visual and physical-cognitive 
performance [6], although measurments of visual and visual-
cognitive performance were somewhat flawed in the study 
design, so remain inconclusive. Overall, this previous reserch 
showed there was an impact performance due to MS, where 
this current paper now aims to determine if more severe MS 
leads to increased decrement in performance (and vice-
versa). Another important unanswered question. 
V. METHOD 
To assess how MS affects every possible driving related 
task is not possible. Instead, the human performance diagram 
(Fig. 1) was created so any possible driving task can be 
mapped to the diagram. E.g., route-planning falls within the 
cognitive performance section, pressing a button (requiring 
visual skill and physical dexterity) would fit in the physical-
visual section, and interacting with an out-of-sign control 
may rely on just physical performance. Six assessments were 
chosen based on a few criteria: they should be pre-validated 
and standardized tests, they should each take less than 1 
minute to complete, they should have no learning affect (i.e., 
once familiar with the test, repeated exposures should not 
affect the scores) and they should represent the section 
assigned - remaining independent of the others as much as 
practically possible. This methodology was used in 
previously published research by the same authors [6]. The 
pre-validated tests chosen included:  
Test 1 - Visual performance: A visual acuity ETDRS LogMar 
test chart was used. Participants used their dominant eye, 
standing at a set distance and were scored on the total number 
of letters read. 
Test 2 - Physical performance: ‘Card turning’ from the 
‘Jebson Taylor Hand Function Test’ [23] was used. 3”x5” 
white index cards used were used on a dark table to reduce 
the impact of visual ability. The time taken to turn all five 
cards using their dominant and non-dominant hand served as 
the score.  
Test 3 - Cognitive performance: A ‘Paced Visual Serial 
Addition Test’ (PVSAT) was used - a visual version of an N-
Back test. See [24]) for N-Back. A laptop was used to present 
numbers and participants had to add the current number to the 
previously shown number and give the answer verbally. 
Numbers were presented in black text with 200pt font size on 
a white background to reduce any effect of visual 
performance (20 numbers were shown for 1 second with a 
gap of 2 seconds). The total number of correct answers gave 
the participants score. 
Test 4 – Visual-cognitive performance: A mental rotation test 
was used [25] where a 3D shape was presented on paper 
alongside four other shapes, the task was to identify which 
two shapes matched the target shape, despite being rotated. 
Participants were scored on the number of complete answers 
of which there were 8, giving a maximum score of 4 . 
Test 5 - Physical-visual performance: The Perdue Pegboard  
[26] was used . Participants tested with their dominant and 
non-dominant hand independently and were scored on the 
number of pins they located in the holes in the given time (60 
seconds). 
Test 6 – Physical-cognitive performance: A reaction time test 
was used where a large traffic light was displayed on a laptop 
screen, when the bottom green light illuminated (randomly 
between 1 and 6 seconds) participants pressed a physical 
button. This test relied on cognitive processing speed and 
physical response. Participants were timed for five repetitions 
and score was derived from the average. 
 
For the MS ‘stimulus’ a route was designed for the 3xD 
Vehicle Simulator at the University of Warwick [27]. A 
simulator was used as it offers controllability over external 
variables, and, most importantly ensures participant safety as 
the effects of MS were unknown. All participants were made 
aware of any risks, were welcomed to end the trial at any time 
and were monitored throughout. When participants arrived, 
they completed the Simulation Sickness Questionnaire 
(SSQ) [28] to identify pre-existing conditions. They were 
introduced to all six performance tasks and ran through each 
as a training activity. The six tests were given again in a 
random order and baseline scores were recorded. Participants 
were then introduced to the driving simulator and drove 
along the pre-planned route for up to 30-minutes (including 
5-minutes of familiarization) along a mixture of country, 
rural and motorway roads. The participant and researcher 
were in constant communication to monitor wellbeing, where 
scores were taken every minute to rate their MS as per the 
Fast Motion Sickness or ‘FMS’ scale [29]. After the driving, 
participants completed the six tests again (in a random order) 
and completed another SSQ. MS was likely to wear off after 
simulator use (although a precise subjective recovery time is 
argued), so tests were given within the first six minutes of the 
driving ending. Data from this paper will be analyzed looking 
at delta human performance scores (i.e., the difference before 
and after simulator use) and compared to delta MS scores. 
Where the SSQ was used to infer MS state, the mechanism 
through which motion sickness is a result is irrelevant, where 
levels of SSQ score are transferable across any application, 
including seasickness, carsickness etc.  
 
The aim of the study was not to induce MS, but rather 
expose participants to an extended situation (up to 30 
minutes) where MS was possible, and measure the range of 
responses. When adhering to best practice guidelines the 3xD 
simulator does not cause excessive MS. These best practices 
include limiting simulator exposure to ~15 minutes, venting 
cool air into the cabin (as provided), completion of a 
familiarization run (as completed), pre-screening participants 
for a propensity for MS and avoiding complex junctions / 
higher speed sweeping bends. e were specifically interested 
in the effect of MS on performance, hence a longer duration 
of scenario (30 minutes) which in the final 10 minutes 
exposed participants to increasingly complex turns. A 
prescreening questionnaire was completed and those who 
indicated flagged responses were given a written and verbal 
warning that they might experience MS and given the 
opportunity to withdraw. As we are exposing people to a 
scenario which might increase the likelihood of MS, 
continuous monitoring (through FMS and visually) of the 
participant was completed. This study was approved through 
The University of Warwick BSREC (REGO-2017-2090). 
VI. RESULTS 
51 participants took part with 27 males and 24 females. The 
minimum participant age (age was reported in groups) was 
22 ± 4 years, with a maximum age of 49 ± 4 years, a mean 
age of 31 and a standard deviation of 10.13. An exploratory 
analysis for task completion and MS are presented. Where 
abbreviations ‘Dom’ refer to dominant hand, ‘Non.Dom’ to 
non-dominant hand and 'Av.Time’ refers to average time. 
TABLE I.  DESCRIPTIVE STATISTICS 
 
Looking at average change in mean scores for all 
participants Test 1 indicated improvement, Test 2 a 
deterioration, Test 3 deterioration , Test 4 an improvement, 
Test 5 a deterioration , and Test 6 a deterioration . Regarding 
the analysis of performance on MS severity , participants 
were split into three equal groups of 17 participants, based on 
individual MS severity where group 1 contained participants 
with the lowest Δ(delta) MS scores, group 2 consisted of the 
next 17 participants and group 3 consisted of the final 17 
participants with the greatest Δ MS scores. An ANOVA 
showed a significant difference between the three groups’ 
SSQ scores (F=81.272, p<0.001) 
TABLE II.  DESCRIPTIVE STATISTICS OF GROUPS 
 
Change in performance (Δ performance) is mapped against 
the change in Total SSQ score averages for the three severity 
groups (Group 1 contains those with the lowest MS scores 
and Group 3 contains those with the highest). And presented 
in Fig. 2,3,4,5,6 and 7 below: 
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1(Visual) Score 1.055 0.093 1.056 0.09 0.001 
2(Physical) Dom 3.813 0.617 4.025 0.737 0.212 
Non. 
Dom 
4.015 0.835 4.289 0.81 0.274 
3(Cognitive)  Score 18.196 1.184 17.569 1.769 -0.627 
4(Visual-
Cognitive) 
Score 3.157 1.027 3.235 0.971 0.078 
Time 79.821 43.789 74.878 43.738 -4.943 
5(Physical-
Visual) 
Dom 16.039 1.673 15.529 1.641 -0.51 
Non. 
Dom 
14.765 1.531 14.471 1.419 -0.294 
6(Physical-
Cognitive) 
Av. 
Time 
0.3 0.038 0.324 0.056 0.024 
SSQ Total Score 
39.639 59.901 
495.96
3 
333.12
7 
456.3
24 
SSQ Nausea Score 
2.618 6.057 46.492 36.737 
43.87
4 
SSQ 
Oculomotor 
Score 
5.797 8.246 33.441 21.662 
27.64
4 
SSQ 
Disorientati
on 
Score 
2.183 5.113 52.678 42.797 
50.49
5 
Group Mean Standard Deviation Standard Error 
1 (n=17) 137.133 106.702 25.150 
2 (n=17) 416.925 86.745 21.686 
3 (n=17) 831.369 222.294 53.914 
  
 
 
 
 
 
 
 
 
 
Fig. 2. Change in visual performance across three MS groups. 
 
 
 
 
 
 
 
 
 
Fig. 3. Change in cognitive performance across three MS groups. 
 
 
 
 
 
 
 
 
 
Fig. 4. Change in physical performance across three MS groups. 
 
 
 
 
 
 
 
 
 
Fig. 5. Change in visual-cognitive performance across three MS groups. 
 
 
 
 
 
 
 
 
 
Fig. 6. Change in physical-visual performance across three MS groups. 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Change in physical-cognitive performance across three MS groups. 
Using a Levene Test for Homogeneity of Variance it was 
found that Test 2 (Physical) and 6 (Physical-Visual) exhibited 
significance where F(2,48)=4.667, p=0.014 and 
F(92,48)=4.255, p=0.02 respectively. The Welch ANOVA 
will be used for analyzing Test 2 and 6. The other four Test 
data sets met all assumptions so an ANOVA was used. The 
result of the ANOVA found no statistical significance 
between the three groups in Tests 1, 3, 4 or 5 where p>0.05 
in all cases. Using the Welch ANOVA no statistical 
significance was found for Test 2 where p>0.05. However, 
for Test 6 (physical-visual) statistical significance was found 
F(2,27.168)=3.468, p=0.046. For Test 6 the Scheffe post-hoc 
analysis showed a statistically significant difference between 
group 1 and 2 (p=0.035) and group 2 and 3 (p=0.026), 
however there was no difference between groups 1 and 3 
(p>0.05). Looking at another method for grouping the data, 
participants were split using total SSQ score percentiles 
where group 1 (25th%ile) scored ≤203.21 (n=12), Group 2 
(26th-74th%ile) scored between 203.21 and 606.965 (n=18) 
and group 3 (75th%ile) scored ≥606.965 (n=21). No statistical 
significance between MS severity groups and change in 
performance was found in any group where p>0.05 in all 
cases.  
VII. DISCUSSION 
Previously it was shown that motion sickness (MS) had a 
significant effect on cognitive, physical, physical-visual and 
physical-cognitive performance [6]. Where the binary 
categorization of motion sick or not was based on participants 
dropping out of the study due to sickness, or being able to 
complete the driving. Test 1 (visual performance) was flawed 
due to uncontrollable lighting–highlighting the impact of 
luminance on acuities. Test 4 (visual-cognitive), was also 
somewhat flawed since the interesting finding that the mental 
rotation test used is affected by simulator use regardless of 
MS [6]. Hence, the relationship between MS and Test 1 
(visual) and 4 (visual-cognitive) is inconclusive.  
 
Looking at the six graphs presented in this study (Fig. 2-
7), there was a visual indication that this MS effect may be 
scalable whereby those with higher MS may have a greater 
impact than those who have lower MS. However, the 
statistics do not bear this out, hence there is very little reason 
to believe that an increased SSQ score (subjective MS) has 
an effect on the scale of change in task performance ability. 
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Although one significant result was found in Test 6 (physical-
visual) although with only two of the three groups being 
different there isn’t enough data to point to a scale effect, 
where a minimum of three points is needed to indicate a trend. 
Further, it is interesting to see how the lowest MS group (1) 
and the highest MS group (3) were no different, further 
supporting that MS severity had no scale of impact on 
performance. The findings from this analysis reveals the scale 
of the effect of MS on human performance varies greatly 
between participants, where the range of performance effects 
are largely independent of SSQ total score severity based on 
our methods of grouping. This means that it is, at this time, 
impossible to predict if someone with lower subjective MS 
will exhibit a greater or lesser change in their task 
performance ability than someone with higher subjective MS.  
 
The results presented are limited by participants’ ability 
to accurately rate subjective MS score using the SSQ. This is 
perhaps a limitation of the field in general whereby the 
subjective scale of the SSQ and other MS questionnaires may 
not be accurate and/or precise enough to really grasp true MS 
state. Although, at this time there are no widely accepted 
subjective or physiological alternatives available. A 
secondary limitation which may have affected results is the 
method(s) used to group participants. To date, no one has 
made a successful method of categorizing the SSQ in terms 
of severity groups. One paper [30] attempted a method 
although the groups overlapped and the scale used was based 
on a maximum SSQ score of “~300” which is not comparable 
to the true SSQ maximum score (2437.9).  
 
Given what we know about the cause(s) of MS, it is 
possible to speculate that the change in human performance 
may be better physiologically/biologically explained, rather 
than subjectively. Where it is possible the effect of something 
such as sensory conflict may affect the body in such a way 
that is not necessarily measurable through subjective MS (at 
least accurately), but is impactful on performance. It should 
be recognized the MS ‘induced’ in this study was specifically 
‘simulation sickness’, thus the transferability to carsickness 
or other forms of MS cannot be commented on with this data 
set. It is thought feelings may to differ somewhat in scale 
especially between the categories of nausea, oculomotor and 
disorientation feelings, where in sensory conflict the 
stationary and moving cues are opposite in a simulator to ‘real 
world’. However, there is little reason to believe the effect (or 
lack thereof) of severity of MS and impact on performance is 
likely to be different in other MS states. 
 
Not much is known currently about the actual role of the 
occupant in a level 3-5 automated vehicle. However, 
considering a vehicle with level 3-4 technology - where the 
driver is required to retake control if necessary in level 3 
(conditionally automated), and has the option to take over in 
level 4 (highly automated), it needs to be explored if human 
performance skills are affected if the ‘driver’ is influenced by 
MS, especially now it is known the scale of the effect may be 
independent from the scale of their subjective MS. This 
increases complexity of MS management within self-driving 
vehicles. Where previously it may be thought that only 
severely motion sick participants will be affected, the data 
presented from this user trial shows that people with varying 
(even low) severity of subjective MS may be affected just as 
much. This is an area that requires further investigation, 
where requiring/allowing someone to take over control of a 
vehicle when they are cognitively, visually or physically 
impaired due to the self-driving vehicle is a concern. It is not 
possible at this point to say whether or not results discussed 
in this paper, or the previous paper by the authors, are likely 
to impact specific driving skills, but this does highlight the 
need for further investigation. For example, a well cited 
report has previously set out recommendations for a safe 
vehicle handover, yet the recommendations are based on a 
driver with presumed normal human performance ability 
[31]. Within this report they advised a lead-time of 10 
seconds between when a takeover request is given to the 
driver and when the driver should be expected to regain 
control of the vehicle. If, for instance, the driver was suffering 
from MS, even with subjectively low discomfort (and 
therefore their visual/cognitive/physical task performance 
was suffering) it needs to be understood if this will impact 
their ability to regain control of a vehicle within this 10 
second timeframe, particularly when subjective recovery 
takes, for the most part, between 15-30 minutes [32]. Other 
sources have also recommended similar handover times of 10 
seconds or less, for example, Audi’s ‘Traffic Jam Pilot’ (level 
3 conditionally automated vehicle) which will give a 10 
second warning before giving back control. This highlights a 
significant miss-match between what is to be expected of 
users (10 seconds), and what may be possible by severely or 
acutely MS ‘drivers’ (15-30 minutes). 
VIII. CONCLUSION 
Many automotive manufactures are hoping to get cars 
with at least level 3 autonomy onto roads as soon as possible 
- KPMG predicts rollout of such technology from as early as 
2020 [1] (p.7). If automakers want to meet their current 
targets, it will be imperative that human factors research is 
considered, such as that presented here and subsequent 
recommendations are effectively implemented in vehicles. 
The literature explains self-driving vehicles (levels 3-5) are 
expected to increase MS onset frequency and severity (an 
estimated 52.7% of Indian adults will likely be affected for 
example [11]). This, and previous [6], research has shown 
how such MS can also affect various areas of human 
performance.  
The results presented in this paper show that the scale of 
the effect of decreased human performance is, for the most 
part, independent of subjective MS severity - where people 
with lower subjective MS are affected in a comparable way 
to those who have higher subjective severity. Meaning 
although someone may only be feeling slightly motion sick, 
the impact of that motion sickness on their performance many 
be just as severe as one with greater motion sickness feelings. 
The consequence of this for self-driving vehicles (which may 
induce motion sickness for some) needs to be seriously 
considered. This paper has also highlighted that perhaps 
subjective scoring is not an effective way of grading motion 
sickness severity. This paper has taken the first steps in 
understanding a new area of research that has yet to be fully 
explored. Based on the initial findings presented here there is 
good reason to recommend further research in: (1) exploring 
the ability to categorise MS severity states (subjectively or 
otherwise) with an aim to understand further the impact on 
human performance, and (2) the exact impact (if any) of MS 
on self-driving car specific ‘driver’ requirements from a 
competency perspective (such as vehicle handover safety).  
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